Phosphine

Phosphine

SCHEMBL28022453

CC(=O)OC(=O)C(N)CC(=O)O.CC(=O)OC(=O)C(N)CC(=O)O.CC(=O)OC(=O)C(N)CC(=O)O.CC(=O)OC(=O)C(N)CC(=O)[O-].P.[Na+]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phosphine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CA2 known ✓ P00918 1/20 0.35
▸ CA4 known ✓ P22748 1/20 0.31
▸ ALOX15 P16050 1/20 0.35
▸ CPT2 P23786 1/20 0.33
▸ CPT1A P50416 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ LMNA P02545 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ GRIK1 P39086 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL27761535 0.93 CA2 (0.40) CA2CPT2CPT1AMEN1CYP1A2
SCHEMBL27969565 0.91 CA2 (0.41) CA2CPT2CPT1AMEN1CYP1A2
Phosphine SCHEMBL27661468 0.89 ALOX15 (0.37) ALOX15LMNASMN1; SMN2GRIK1
SCHEMBL4656229 0.88 CPT2 (0.38) CA2CPT2CPT1AMEN1CYP1A2
Potassium Ion SCHEMBL31723413 0.88 CPT2 (0.38) CA2CPT2CPT1AMEN1CYP1A2
SCHEMBL1824385 0.88 ALOX15 (0.38) ALOX15LMNASMN1; SMN2GRIK1
SCHEMBL4656227 0.86 ALOX15 (0.37) ALOX15LMNASMN1; SMN2GRIK1
Methane SCHEMBL28312792 0.86 ALOX15 (0.37) ALOX15LMNASMN1; SMN2GRIK1
SCHEMBL27856278 0.86 ALOX15 (0.37) ALOX15LMNASMN1; SMN2GRIK1
Butane SCHEMBL1173128 0.82 GRIK1 (0.35) ALOX15LMNASMN1; SMN2GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104736144-B Efflux inhibitor compositions and methods of treatment using such compositions 艾祖米科技有限公司 2019-02-01 — — CN disclosed
CN-107530410-A Fusion proteins comprising modified alphavirus surface glycoproteins and tumor-associated antigens and methods thereof 欧姆尼赛特有限公司 2018-01-02 — — CN disclosed
CN-102698287-B The method for showing the promoter of endothelial cell specific and angiogenesis being adjusted using it 脉管生物生长有限公司 2017-06-13 — — CN disclosed
CN-104854107-A Pyrrolopyrimidine compounds as kinase inhibitors PHARMACYCLICS INC 2015-08-19 — — CN disclosed
Send feedback